• BIVDA members area

Members' Press Releases

EKF introduces mobile data management solution for the DiaSpect Tm POC hemoglobin analyzer

Cardiff, UK – 13th November 2017 – EKF Diagnostics, the global in vitro diagnostics company, today introduces POC Connect - a data management smartphone application for its DiaSpect Tm hemoglobin analyzer. At Medica 2017 on Stand H3/C70, EKF will be highlighting how DiaSpect Tm is the only reagent-free hemoglobin analyzer with mobile connectivity. Lightweight and palm-sized, the DiaSpect Tm analyzer delivers laboratory quality hemoglobin results within 2 seconds at the point-of-care (POC). Now with the availability of POC Connect, this makes it ideal for mobile health checks and anemia screening in a range of locations, environments and climatic conditions.

Read the rest of entry »

Game Changer for Bladder Cancer Diagnosis

ADXBLADDER, an exciting new non-invasive test for bladder cancer from Arquer Diagnostics Ltd. and distributed in the UK by Alpha Laboratories, has just been launched at the Societe Internationale D’Urologie (SIU) meeting in Lisbon. During a live symposium, global participants heard from key opinion leaders and clinicians involved in the development and trial of the new test.

Read the rest of entry »

NEW TEST COULD REVOLUTIONISE THE DIAGNOSIS OF ‘SUPERBUGS’

A new exhibition at the Science Museum, London will feature an invention from the Oxford area which could revolutionise the diagnosis of ‘Superbugs’

Read the rest of entry »

NEW TEST COULD REVOLUTIONISE THE DIAGNOSIS OF ‘SUPERBUGS’

 

A new exhibition at the Science Museum, London will feature an invention from the Oxford area which could revolutionise the diagnosis of ‘Superbugs’

Read the rest of entry »

SpeeDx receives CE-IVD mark for multiplex PlexPCR® VHS test for VZV, herpes and syphilis

SYDNEY, AUSTRALIA–(October 25, 2017). SpeeDx Pty. Ltd. has announced that it has received CE-IVD marking for its PlexPCR® VHS multiplex qPCR test. The test offers a single-well solution to cover the detection and differentiation of the main causes of genital and oral lesions: herpes simplex virus types 1 and 2 (HSV-1, HSV-2), Treponema pallidum (syphilis), and varicella zoster virus (VZV). Validated for use on multiple lesion specimen types, the test is designed to streamline workflows and support rapid, appropriate clinical management of infections with similar symptoms.

Read the rest of entry »

New Advanced Pipetting Academy Makes You a Pipetting Master

For many years Alpha Laboratories and Sartorius have delivered a popular training programme covering correct pipetting techniques, the ergonomic use of pipettes, plus basic service and maintenance of pipettes in everyday laboratory use. User feedback has now led to the development of the Advanced Pipetting Academy™ to address the unique requirements of individual laboratories.

Read the rest of entry »

Abingdon Health Ltd (“Abingdon”) has announced its entry in the UK Parliamentary Review 2017 (“The Review”) has now been published.

While focusing on 12 key government policy areas, the Review, which is distributed to Policymakers in the UK and abroad, allows leading organisations and executives to share personal insight as well as discuss good practice alongside Cabinet and senior ministers.

Read the rest of entry »

BBI Solutions adds more antibodies to product range

BBI Solutions has continued to invest in its portfolio of antibodies and today announced the launch of 10 infectious disease markers, 3 inflammatory markers, 2 fertility markers and an additional cardiac marker. All the antibodies have been tested in either lateral flow or ELISA and are available for sampling today.

Read the rest of entry »

Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK

Alpha Laboratories Ltd. (Eastleigh, UK) is delighted to have been appointed as the exclusive distributor for Arquer Diagnostics Ltd (“Arquer”) in the UK and Republic of Ireland. Arquer (Sunderland, UK) is an in-vitro diagnostic company developing breakthrough diagnostic tests for the detection of bladder and prostate cancer. Its non-invasive cancer diagnostic tests are based on the MCM5 (minichromosome maintenance protein) platform. The first Arquer product is ADXBLADDER, a bladder cancer diagnostic test, and a number of clinical trials are running to validate many other indications. 

Read the rest of entry »

New Partnership for Biological Sample Transport Solutions

Specialist Laboratory and Diagnostics supply company Alpha Laboratories Ltd. (Eastleigh, UK) is delighted to announce that it has been appointed the exclusive UK distributor for MedDX Solutions Ltd. (Hereford, UK). This partnership will further strengthen the range of solutions provided for biological sample collection and transportation, which ensure compliance with UN3373 and P650 packaging regulations. 

Read the rest of entry »

Pages: Previous1234567...31NextReturn Top

Archive